[1] Friedman S H, DeCamp D L, Sijbesma R P, Srdanov G, Wud F, Kenyon G L. Inhibition of the HIV-1 protease by fullerene derivatives:model building studies and experimental verification[J]. Journal of the American Chemical Society, 1993, 115(15):6506-6509.
[2] Lyon D Y, Adams L K, Falkner J C, Alvarezt P J. Antibacterial activity of fullerene water suspensions:effects of preparation method and particle size[J]. Environmental Science & Technology, 2006, 40(14):4360-4366.
[3] Li J, Guan M R, Wang T S, Zhen M M, Zhao F W, Shu C Y, Wang C R. Gd@C82-(ethylenediamine)8 nanoparticle:a new high-efficiency water-soluble ROS scavenger[J]. ACS Applied Materials & Interfaces, 2016, 8(39):25770-25776.
[4] Zhou Y, Li J, Ma H J, Zhen M M, Guo J, Wang L P, Jiang L, Shu C Y, Wang C R. Biocompatible
[60] /
[70] fullerenols:potent defense against oxidative injury induced by reduplicative chemotherapy[J]. ACS Applied Materials & Interfaces, 2017, 9(41):35539-35547.
[5] Zhang Y, Shu C Y, Zhen M M, Li J, Yu T, Jiang W, Li X, Deng R J, Zhou Y, Wang C R. A novel bone marrow targeted gadofullerene agent protect against oxidative injury in chemotherapy[J]. Science China Materials, 2017, 60(9):866-880.
[6] Guan M R, Ge J C, Wu J Y, Zhang G Q, Chen D Q, Zhang W, Zhang Y, Zou T J, Zhen M M, Wang C R, Chu T W, Hao X J, Shu C Y. Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy[J]. Biomaterials, 2016, 103:75-85.
[7] Zhou Y, Deng R J, Zhen M M, Li J, Guan M R, Jia W, Li X, Zhang Y, Yu T, Zou T J, Lu Z G, Guo J, Sun L, Shu C Y, Wang C R. Amino acid functionalized gadofullerene nanoparticles with superior antitumor activity via destruction of tumor vasculature in vivo[J]. Biomaterials, 2017, 133:107-118.
[8] Chen C Y, Xing G M, Wang J X, Zhao Y L, Li B, Tang J, Jia G, Wang T C, Sun J, Xing L, Yuan H, Gao Y X, Meng H, Chen Z, Zhao F, Chai Z F, Fang X H. Multihydroxylated[Gd@C82(OH)22]<i>n nanoparticles:antineoplastic activity of high efficiency and low toxicity[J]. Nano Letters, 2005, 5(10):2050-2057.
[9] Zhen M M, Shu C Y, Li J, Zhang G Q, Wang T S, Luo Y, Zou T J, Deng R J, Fang F, Lei H, Wang C R, Bai C L. A highly efficient and tumor vascular-targeting therapeutic technique with size-expansible gadofullerene nanocrystals[J]. Science China Materials, 2015, 58(10):799-810.
[10] Siemann D W, Bibby M C, Dark G G, Dicker A P, Eskens F A, Horsman M R, Marmé D, Lorusso P M. Differentiation and definition of vascular-targeted therapies[J]. Clinical Cancer Research, 2005, 11:416-420.
[11] Dowlati A, Robertson K, Cooney M, Petros WP, Stratford M, Jesberger J, Rafie N, Overmoyer B, Makkar V, Stambler B, Taylor A, Waas J, Lewin JS, McCrae K R, Remick SC. A phase Ⅰ pharmacokinetic and translational study of the novel vascular targeting agent combretasta-tin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer[J]. Cancer Research, 2002, 62(12):3408-3416.
[12] Wang C, Bai Y, Li H, Liao R, Li J, Zhang H, Zhang X, Zhang S, Yang S T, Chang XL. Surface modification-mediated biodistribution of 13C-fullerene C60 in vivo[J]. Particle and Fibre Toxicology, 2016, 13:14. |